Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |